Novel motif:39: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:42, 9 September 2013
name: | motif39_CCAAGT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032501 | multicellular organismal process | 1.913577e-15 |
GO:0002695 | negative regulation of leukocyte activation | 1.496243e-13 |
GO:0050896 | response to stimulus | 1.625313e-12 |
GO:0051250 | negative regulation of lymphocyte activation | 2.168784e-12 |
GO:0009653 | anatomical structure morphogenesis | 1.367254e-11 |
GO:0043252 | sodium-independent organic anion transport | 1.857695e-11 |
GO:0050866 | negative regulation of cell activation | 2.029004e-11 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 9.936072e-11 |
GO:0032502 | developmental process | 2.151458e-10 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.596554e-10 |
GO:0051336 | regulation of hydrolase activity | 4.466500e-10 |
GO:0007275 | multicellular organismal development | 5.372223e-10 |
GO:0010035 | response to inorganic substance | 5.527772e-10 |
GO:0051249 | regulation of lymphocyte activation | 8.058078e-10 |
GO:0048731 | system development | 1.319211e-9 |
GO:0072358 | cardiovascular system development | 1.344199e-9 |
GO:0002683 | negative regulation of immune system process | 1.447292e-9 |
GO:0014075 | response to amine stimulus | 1.664264e-9 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1.740799e-9 |
GO:0042221 | response to chemical stimulus | 3.524697e-9 |
GO:0010038 | response to metal ion | 3.814447e-9 |
GO:0048856 | anatomical structure development | 3.866240e-9 |
GO:0031099 | regeneration | 5.201267e-9 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 5.752119e-9 |
GO:0001101 | response to acid | 5.757006e-9 |
GO:0060574 | intestinal epithelial cell maturation | 6.726882e-9 |
GO:0043200 | response to amino acid stimulus | 6.764348e-9 |
GO:0002694 | regulation of leukocyte activation | 9.143225e-9 |
GO:0007154 | cell communication | 1.009048e-8 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 1.099256e-8 |
GO:0019805 | quinolinate biosynthetic process | 1.142081e-8 |
GO:0051659 | maintenance of mitochondrion location | 1.169077e-8 |
GO:0043067 | regulation of programmed cell death | 1.210957e-8 |
GO:0042981 | regulation of apoptosis | 1.516821e-8 |
GO:0051716 | cellular response to stimulus | 1.543758e-8 |
GO:0019853 | L-ascorbic acid biosynthetic process | 1.578945e-8 |
GO:0002828 | regulation of type 2 immune response | 1.778865e-8 |
GO:0023052 | signaling | 1.933785e-8 |
GO:0043009 | chordate embryonic development | 1.937738e-8 |
GO:0006950 | response to stress | 1.980374e-8 |
GO:0051657 | maintenance of organelle location | 2.449003e-8 |
GO:0070541 | response to platinum ion | 2.565166e-8 |
GO:0050789 | regulation of biological process | 2.680545e-8 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 2.710352e-8 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 2.717158e-8 |
GO:0048513 | organ development | 2.775003e-8 |
GO:0044419 | interspecies interaction between organisms | 3.688014e-8 |
GO:0010941 | regulation of cell death | 4.774124e-8 |
GO:0009792 | embryo development ending in birth or egg hatching | 5.846023e-8 |
GO:0009605 | response to external stimulus | 6.112058e-8 |
GO:0050790 | regulation of catalytic activity | 6.312216e-8 |
GO:0032689 | negative regulation of interferon-gamma production | 8.337044e-8 |
GO:0007165 | signal transduction | 8.584024e-8 |
GO:0022414 | reproductive process | 8.606054e-8 |
GO:0000003 | reproduction | 8.921270e-8 |
GO:0030261 | chromosome condensation | 9.523203e-8 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 1.021978e-7 |
GO:0032910 | regulation of transforming growth factor beta3 production | 1.089013e-7 |
GO:0045109 | intermediate filament organization | 1.139146e-7 |
GO:0046874 | quinolinate metabolic process | 1.240611e-7 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.302159e-7 |
GO:0006182 | cGMP biosynthetic process | 1.373893e-7 |
GO:0032703 | negative regulation of interleukin-2 production | 1.685801e-7 |
GO:0060548 | negative regulation of cell death | 2.056874e-7 |
GO:0034104 | negative regulation of tissue remodeling | 2.121322e-7 |
GO:0043316 | cytotoxic T cell degranulation | 2.156737e-7 |
GO:0050865 | regulation of cell activation | 2.253507e-7 |
GO:0070663 | regulation of leukocyte proliferation | 2.461361e-7 |
GO:0002830 | positive regulation of type 2 immune response | 2.521459e-7 |
GO:0046851 | negative regulation of bone remodeling | 2.953855e-7 |
GO:0050794 | regulation of cellular process | 3.147544e-7 |
GO:0045779 | negative regulation of bone resorption | 3.455077e-7 |
GO:0048583 | regulation of response to stimulus | 3.496732e-7 |
GO:0016032 | viral reproduction | 3.510015e-7 |
GO:0010269 | response to selenium ion | 3.546954e-7 |
GO:0002376 | immune system process | 3.763470e-7 |
GO:0046578 | regulation of Ras protein signal transduction | 4.260691e-7 |
GO:0002831 | regulation of response to biotic stimulus | 4.293698e-7 |
GO:0014866 | skeletal myofibril assembly | 4.687891e-7 |
GO:0006952 | defense response | 4.765460e-7 |
GO:0035051 | cardiac cell differentiation | 4.838931e-7 |
GO:0044238 | primary metabolic process | 4.956145e-7 |
GO:0048739 | cardiac muscle fiber development | 5.028188e-7 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 5.401919e-7 |
GO:0032731 | positive regulation of interleukin-1 beta production | 5.430934e-7 |
GO:0002682 | regulation of immune system process | 5.636824e-7 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 5.675432e-7 |
GO:0070664 | negative regulation of leukocyte proliferation | 5.699046e-7 |
GO:0065007 | biological regulation | 5.925495e-7 |
GO:0009888 | tissue development | 6.641345e-7 |
GO:0006936 | muscle contraction | 6.791969e-7 |
GO:0032732 | positive regulation of interleukin-1 production | 7.265787e-7 |
GO:0050863 | regulation of T cell activation | 7.609309e-7 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 8.878396e-7 |
GO:0048468 | cell development | 9.113136e-7 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 9.355606e-7 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 9.417546e-7 |
GO:0052548 | regulation of endopeptidase activity | 1.028442e-6 |
GO:0050955 | thermoception | 1.037715e-6 |
GO:0043154 | negative regulation of caspase activity | 1.048657e-6 |
GO:0010466 | negative regulation of peptidase activity | 1.051718e-6 |
GO:0001834 | trophectodermal cell proliferation | 1.277581e-6 |
GO:0012501 | programmed cell death | 1.354913e-6 |
GO:0050868 | negative regulation of T cell activation | 1.458015e-6 |
GO:0006935 | chemotaxis | 1.523029e-6 |
GO:0048869 | cellular developmental process | 1.619648e-6 |
GO:0042157 | lipoprotein metabolic process | 1.793171e-6 |
GO:0060118 | vestibular receptor cell development | 1.932865e-6 |
GO:0006807 | nitrogen compound metabolic process | 1.960257e-6 |
GO:0065009 | regulation of molecular function | 1.989624e-6 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 2.024389e-6 |
GO:0032855 | positive regulation of Rac GTPase activity | 2.038229e-6 |
GO:0043069 | negative regulation of programmed cell death | 2.038566e-6 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 2.108658e-6 |
GO:0030154 | cell differentiation | 2.183183e-6 |
GO:0006955 | immune response | 2.216579e-6 |
GO:0046078 | dUMP metabolic process | 2.298331e-6 |
GO:0032318 | regulation of Ras GTPase activity | 2.463412e-6 |
GO:0034754 | cellular hormone metabolic process | 2.516590e-6 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 2.617631e-6 |
GO:0042127 | regulation of cell proliferation | 2.624317e-6 |
GO:0007059 | chromosome segregation | 2.706226e-6 |
GO:0007507 | heart development | 2.779403e-6 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 2.785112e-6 |
GO:0022410 | circadian sleep/wake cycle process | 2.786022e-6 |
GO:0052547 | regulation of peptidase activity | 2.828506e-6 |
GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway | 2.847621e-6 |
GO:0019222 | regulation of metabolic process | 2.906686e-6 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 3.389182e-6 |
GO:0007623 | circadian rhythm | 3.392046e-6 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.431712e-6 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 3.431712e-6 |
GO:0001501 | skeletal system development | 3.448735e-6 |
GO:0061043 | regulation of vascular wound healing | 3.535207e-6 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 3.808125e-6 |
GO:0042752 | regulation of circadian rhythm | 3.889180e-6 |
GO:0009887 | organ morphogenesis | 4.461483e-6 |
GO:0000279 | M phase | 4.499797e-6 |
GO:0055013 | cardiac muscle cell development | 4.779940e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.795931e-6 |
GO:0051345 | positive regulation of hydrolase activity | 4.945175e-6 |
GO:0001657 | ureteric bud development | 4.952897e-6 |
GO:0032989 | cellular component morphogenesis | 5.029142e-6 |
GO:0009074 | aromatic amino acid family catabolic process | 5.178383e-6 |
GO:0043094 | cellular metabolic compound salvage | 5.208954e-6 |
GO:0009611 | response to wounding | 5.331618e-6 |
GO:0002832 | negative regulation of response to biotic stimulus | 5.489479e-6 |
GO:0055003 | cardiac myofibril assembly | 5.840850e-6 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 5.851027e-6 |
GO:0043066 | negative regulation of apoptosis | 6.090957e-6 |
GO:0042940 | D-amino acid transport | 6.134246e-6 |
GO:0007584 | response to nutrient | 6.365632e-6 |
GO:0032320 | positive regulation of Ras GTPase activity | 6.489800e-6 |
GO:0007049 | cell cycle | 6.577235e-6 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 6.671320e-6 |
GO:0019088 | immortalization of host cell by virus | 6.987186e-6 |
GO:0006231 | dTMP biosynthetic process | 6.987186e-6 |
GO:0055007 | cardiac muscle cell differentiation | 7.083668e-6 |
GO:0002697 | regulation of immune effector process | 7.124977e-6 |
GO:0051346 | negative regulation of hydrolase activity | 7.279260e-6 |
GO:0006820 | anion transport | 7.291911e-6 |
GO:0019363 | pyridine nucleotide biosynthetic process | 7.617003e-6 |
GO:0042745 | circadian sleep/wake cycle | 7.699374e-6 |
GO:0006725 | cellular aromatic compound metabolic process | 7.704690e-6 |
GO:0010811 | positive regulation of cell-substrate adhesion | 8.404798e-6 |
GO:0006915 | apoptosis | 8.481292e-6 |
GO:0048514 | blood vessel morphogenesis | 9.308834e-6 |
GO:0008624 | induction of apoptosis by extracellular signals | 9.404948e-6 |
GO:0050688 | regulation of defense response to virus | 9.589764e-6 |
GO:0002251 | organ or tissue specific immune response | 9.733848e-6 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.902638e-6 |
GO:0001667 | ameboidal cell migration | 1.021876e-5 |
GO:0048512 | circadian behavior | 1.061340e-5 |
GO:0010043 | response to zinc ion | 1.115783e-5 |
GO:0090291 | negative regulation of osteoclast proliferation | 1.158257e-5 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.158257e-5 |
GO:2000349 | negative regulation of CD40 signaling pathway | 1.158257e-5 |
GO:0072573 | tolerance induction to lipopolysaccharide | 1.158257e-5 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 1.158257e-5 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.158257e-5 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.158257e-5 |
GO:0048518 | positive regulation of biological process | 1.228789e-5 |
GO:0048769 | sarcomerogenesis | 1.248283e-5 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.271669e-5 |
GO:0031397 | negative regulation of protein ubiquitination | 1.371831e-5 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 1.384049e-5 |
GO:0006508 | proteolysis | 1.388029e-5 |
GO:0031100 | organ regeneration | 1.421404e-5 |
GO:0060252 | positive regulation of glial cell proliferation | 1.427641e-5 |
GO:0007005 | mitochondrion organization | 1.436519e-5 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.482468e-5 |
GO:0051701 | interaction with host | 1.544014e-5 |
GO:0008219 | cell death | 1.584614e-5 |
GO:0006569 | tryptophan catabolic process | 1.591059e-5 |
GO:0060126 | somatotropin secreting cell differentiation | 1.618062e-5 |
GO:0007093 | mitotic cell cycle checkpoint | 1.635228e-5 |
GO:0033273 | response to vitamin | 1.715903e-5 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 1.720548e-5 |
GO:0035270 | endocrine system development | 1.723365e-5 |
GO:0016265 | death | 1.778633e-5 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 1.782938e-5 |
GO:0006082 | organic acid metabolic process | 1.789314e-5 |
GO:0030239 | myofibril assembly | 1.808898e-5 |
GO:0000302 | response to reactive oxygen species | 1.852832e-5 |
GO:0043547 | positive regulation of GTPase activity | 1.908413e-5 |
GO:0007051 | spindle organization | 1.941160e-5 |
GO:0010628 | positive regulation of gene expression | 2.026547e-5 |
GO:0046850 | regulation of bone remodeling | 2.120484e-5 |
GO:0006568 | tryptophan metabolic process | 2.123071e-5 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 2.141092e-5 |
GO:0046634 | regulation of alpha-beta T cell activation | 2.152231e-5 |
GO:0008347 | glial cell migration | 2.261437e-5 |
GO:0050869 | negative regulation of B cell activation | 2.537617e-5 |
GO:0080090 | regulation of primary metabolic process | 2.548519e-5 |
GO:0010604 | positive regulation of macromolecule metabolic process | 2.602623e-5 |
GO:0010625 | positive regulation of Schwann cell proliferation | 2.603514e-5 |
GO:0032944 | regulation of mononuclear cell proliferation | 2.640269e-5 |
GO:0045124 | regulation of bone resorption | 2.680528e-5 |
GO:0032233 | positive regulation of actin filament bundle assembly | 2.755408e-5 |
GO:0045590 | negative regulation of regulatory T cell differentiation | 2.838442e-5 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 2.841633e-5 |
GO:0031032 | actomyosin structure organization | 2.897545e-5 |
GO:0048522 | positive regulation of cellular process | 2.955868e-5 |
GO:0014032 | neural crest cell development | 3.067928e-5 |
GO:0061008 | hepaticobiliary system development | 3.111825e-5 |
GO:0048729 | tissue morphogenesis | 3.158792e-5 |
GO:0042753 | positive regulation of circadian rhythm | 3.191369e-5 |
GO:0061298 | retina vasculature development in camera-type eye | 3.198242e-5 |
GO:0051704 | multi-organism process | 3.207856e-5 |
GO:0051004 | regulation of lipoprotein lipase activity | 3.241495e-5 |
GO:0019439 | aromatic compound catabolic process | 3.242109e-5 |
GO:0019752 | carboxylic acid metabolic process | 3.267056e-5 |
GO:0050670 | regulation of lymphocyte proliferation | 3.378244e-5 |
GO:0022415 | viral reproductive process | 3.434268e-5 |
GO:0008207 | C21-steroid hormone metabolic process | 3.466069e-5 |
GO:0070779 | D-aspartate import | 3.531412e-5 |
GO:0043031 | negative regulation of macrophage activation | 3.638160e-5 |
GO:0001701 | in utero embryonic development | 3.728906e-5 |
GO:0060322 | head development | 3.894808e-5 |
GO:0001756 | somitogenesis | 3.947057e-5 |
GO:0010761 | fibroblast migration | 3.979776e-5 |
GO:0040011 | locomotion | 3.986821e-5 |
GO:0002385 | mucosal immune response | 4.444057e-5 |
GO:0045630 | positive regulation of T-helper 2 cell differentiation | 4.462155e-5 |
GO:0048519 | negative regulation of biological process | 4.479953e-5 |
GO:0008283 | cell proliferation | 4.505547e-5 |
GO:0065008 | regulation of biological quality | 4.564476e-5 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 4.583005e-5 |
GO:0061053 | somite development | 4.624917e-5 |
GO:0001836 | release of cytochrome c from mitochondria | 4.647206e-5 |
GO:0050864 | regulation of B cell activation | 4.687507e-5 |
GO:0015742 | alpha-ketoglutarate transport | 4.711592e-5 |
GO:0010243 | response to organic nitrogen | 4.728217e-5 |
GO:0045621 | positive regulation of lymphocyte differentiation | 4.756370e-5 |
GO:0070670 | response to interleukin-4 | 4.774099e-5 |
GO:0035023 | regulation of Rho protein signal transduction | 4.849371e-5 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 4.910933e-5 |
GO:0060323 | head morphogenesis | 5.039042e-5 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 5.219001e-5 |
GO:0033153 | T cell receptor V(D)J recombination | 5.258389e-5 |
GO:0001889 | liver development | 5.346571e-5 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 5.389875e-5 |
GO:0010810 | regulation of cell-substrate adhesion | 5.416888e-5 |
GO:0007276 | gamete generation | 5.426388e-5 |
GO:0001954 | positive regulation of cell-matrix adhesion | 5.439500e-5 |
GO:0018874 | benzoate metabolic process | 5.469718e-5 |
GO:0040007 | growth | 5.479360e-5 |
GO:0048771 | tissue remodeling | 5.515745e-5 |
GO:0048644 | muscle organ morphogenesis | 5.548756e-5 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 5.598222e-5 |
GO:0031570 | DNA integrity checkpoint | 5.598446e-5 |
GO:2000348 | regulation of CD40 signaling pathway | 5.606997e-5 |
GO:0010661 | positive regulation of muscle cell apoptosis | 5.606997e-5 |
GO:0042246 | tissue regeneration | 5.728436e-5 |
GO:0035435 | phosphate ion transmembrane transport | 5.906137e-5 |
GO:0043627 | response to estrogen stimulus | 5.933074e-5 |
GO:0048598 | embryonic morphogenesis | 6.035631e-5 |
GO:0016485 | protein processing | 6.154740e-5 |
GO:0003006 | developmental process involved in reproduction | 6.202057e-5 |
GO:0001957 | intramembranous ossification | 6.341217e-5 |
GO:0045581 | negative regulation of T cell differentiation | 6.396006e-5 |
GO:0009966 | regulation of signal transduction | 6.557582e-5 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.598841e-5 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 6.733303e-5 |
GO:0000077 | DNA damage checkpoint | 6.757293e-5 |
GO:0007585 | respiratory gaseous exchange | 6.763516e-5 |
GO:0048538 | thymus development | 6.907792e-5 |
GO:0009435 | NAD biosynthetic process | 7.026414e-5 |
GO:0042180 | cellular ketone metabolic process | 7.039490e-5 |
GO:0044249 | cellular biosynthetic process | 7.078466e-5 |
GO:0045103 | intermediate filament-based process | 7.094049e-5 |
GO:0043615 | astrocyte cell migration | 7.123297e-5 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 7.254081e-5 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 7.334806e-5 |
GO:0048539 | bone marrow development | 7.385590e-5 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 7.669767e-5 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 7.785481e-5 |
GO:0014015 | positive regulation of gliogenesis | 7.822451e-5 |
GO:0006954 | inflammatory response | 7.941835e-5 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 8.033092e-5 |
GO:0001525 | angiogenesis | 8.097688e-5 |
GO:0031016 | pancreas development | 8.265964e-5 |
GO:0015711 | organic anion transport | 8.336739e-5 |
GO:0003012 | muscle system process | 8.356092e-5 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 8.412224e-5 |
GO:0060127 | prolactin secreting cell differentiation | 8.412224e-5 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 8.412224e-5 |
GO:0009893 | positive regulation of metabolic process | 8.466376e-5 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 8.643356e-5 |
GO:0072224 | metanephric glomerulus development | 8.683236e-5 |
GO:0030237 | female sex determination | 8.720787e-5 |
GO:0043087 | regulation of GTPase activity | 8.785138e-5 |
GO:0060290 | transdifferentiation | 8.792819e-5 |
GO:0032652 | regulation of interleukin-1 production | 8.864838e-5 |
GO:0030240 | skeletal muscle thin filament assembly | 8.962975e-5 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 8.992451e-5 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 9.020378e-5 |
GO:0060070 | canonical Wnt receptor signaling pathway | 9.352371e-5 |
GO:0032856 | activation of Ras GTPase activity | 9.469397e-5 |
GO:0042445 | hormone metabolic process | 9.719741e-5 |
GO:0032651 | regulation of interleukin-1 beta production | 9.785047e-5 |
GO:0001568 | blood vessel development | 9.809179e-5 |
GO:0045104 | intermediate filament cytoskeleton organization | 9.855523e-5 |
GO:0042542 | response to hydrogen peroxide | 1.000854e-4 |
GO:0010171 | body morphogenesis | 1.024919e-4 |
GO:0000087 | M phase of mitotic cell cycle | 1.026036e-4 |
GO:0007067 | mitosis | 1.030311e-4 |
GO:0022402 | cell cycle process | 1.031242e-4 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.047213e-4 |
GO:0007622 | rhythmic behavior | 1.060391e-4 |
GO:0015910 | peroxisomal long-chain fatty acid import | 1.065439e-4 |
GO:0006493 | protein O-linked glycosylation | 1.069961e-4 |
GO:0050795 | regulation of behavior | 1.077807e-4 |
GO:0035239 | tube morphogenesis | 1.095261e-4 |
GO:0060562 | epithelial tube morphogenesis | 1.097616e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 1.134673e-4 |
GO:0060324 | face development | 1.144761e-4 |
GO:0008152 | metabolic process | 1.169130e-4 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 1.174690e-4 |
GO:0046512 | sphingosine biosynthetic process | 1.185385e-4 |
GO:0009855 | determination of bilateral symmetry | 1.189174e-4 |
GO:0042703 | menstruation | 1.190754e-4 |
GO:0019101 | female somatic sex determination | 1.190754e-4 |
GO:0051239 | regulation of multicellular organismal process | 1.196935e-4 |
GO:0048285 | organelle fission | 1.204245e-4 |
GO:0006434 | seryl-tRNA aminoacylation | 1.231872e-4 |
GO:0048738 | cardiac muscle tissue development | 1.297054e-4 |
GO:0009799 | specification of symmetry | 1.303492e-4 |
GO:0060700 | regulation of ribonuclease activity | 1.307589e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 1.329136e-4 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1.397530e-4 |
GO:0031667 | response to nutrient levels | 1.412338e-4 |
GO:0006435 | threonyl-tRNA aminoacylation | 1.423738e-4 |
GO:0016055 | Wnt receptor signaling pathway | 1.450141e-4 |
GO:0045582 | positive regulation of T cell differentiation | 1.474429e-4 |
GO:0043900 | regulation of multi-organism process | 1.480201e-4 |
GO:0046483 | heterocycle metabolic process | 1.504471e-4 |
GO:0000819 | sister chromatid segregation | 1.525007e-4 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 1.530946e-4 |
GO:0051496 | positive regulation of stress fiber assembly | 1.575769e-4 |
GO:0002074 | extraocular skeletal muscle development | 1.600029e-4 |
GO:0045589 | regulation of regulatory T cell differentiation | 1.608000e-4 |
GO:0006586 | indolalkylamine metabolic process | 1.622570e-4 |
GO:0015810 | aspartate transport | 1.656507e-4 |
GO:0032101 | regulation of response to external stimulus | 1.676160e-4 |
GO:0032845 | negative regulation of homeostatic process | 1.690683e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.697481e-4 |
GO:0060255 | regulation of macromolecule metabolic process | 1.699615e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.761667e-4 |
GO:0044281 | small molecule metabolic process | 1.890701e-4 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 1.896283e-4 |
GO:0010666 | positive regulation of cardiac muscle cell apoptosis | 1.917728e-4 |
GO:0010927 | cellular component assembly involved in morphogenesis | 2.016070e-4 |
GO:0070098 | chemokine-mediated signaling pathway | 2.033831e-4 |
GO:0006427 | histidyl-tRNA aminoacylation | 2.053055e-4 |
GO:0060973 | cell migration involved in heart development | 2.064086e-4 |
GO:0045329 | carnitine biosynthetic process | 2.158606e-4 |
GO:0043420 | anthranilate metabolic process | 2.179764e-4 |
GO:0034516 | response to vitamin B6 | 2.179764e-4 |
GO:0060442 | branching involved in prostate gland morphogenesis | 2.205486e-4 |
GO:0019953 | sexual reproduction | 2.207265e-4 |
GO:0071779 | G1/S transition checkpoint | 2.222362e-4 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 2.276984e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 2.328725e-4 |
GO:0050870 | positive regulation of T cell activation | 2.447614e-4 |
GO:0045786 | negative regulation of cell cycle | 2.488650e-4 |
GO:0071732 | cellular response to nitric oxide | 2.498591e-4 |
GO:0032663 | regulation of interleukin-2 production | 2.582300e-4 |
GO:0060675 | ureteric bud morphogenesis | 2.597802e-4 |
GO:0033693 | neurofilament bundle assembly | 2.619106e-4 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 2.624596e-4 |
GO:0006414 | translational elongation | 2.630484e-4 |
GO:0009058 | biosynthetic process | 2.642446e-4 |
GO:0033124 | regulation of GTP catabolic process | 2.656421e-4 |
GO:0048545 | response to steroid hormone stimulus | 2.688347e-4 |
GO:0031323 | regulation of cellular metabolic process | 2.734808e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 2.790819e-4 |
GO:0071712 | ER-associated misfolded protein catabolic process | 2.816654e-4 |
GO:0055001 | muscle cell development | 2.889773e-4 |
GO:0050672 | negative regulation of lymphocyte proliferation | 2.902565e-4 |
GO:0043170 | macromolecule metabolic process | 2.905494e-4 |
GO:0060764 | cell-cell signaling involved in mammary gland development | 3.070371e-4 |
GO:0044003 | modification by symbiont of host morphology or physiology | 3.071366e-4 |
GO:0003417 | growth plate cartilage development | 3.098891e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 3.117593e-4 |
GO:0032700 | negative regulation of interleukin-17 production | 3.190335e-4 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 3.201682e-4 |
GO:0048609 | multicellular organismal reproductive process | 3.225006e-4 |
GO:0001503 | ossification | 3.230567e-4 |
GO:0010033 | response to organic substance | 3.361492e-4 |
GO:0016338 | calcium-independent cell-cell adhesion | 3.363655e-4 |
GO:0060415 | muscle tissue morphogenesis | 3.376397e-4 |
GO:0006642 | triglyceride mobilization | 3.498977e-4 |
GO:0051246 | regulation of protein metabolic process | 3.501662e-4 |
GO:0035470 | positive regulation of vascular wound healing | 3.519485e-4 |
GO:0032754 | positive regulation of interleukin-5 production | 3.619528e-4 |
GO:0060325 | face morphogenesis | 3.663182e-4 |
GO:0070849 | response to epidermal growth factor stimulus | 3.667104e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.676930e-4 |
GO:0050678 | regulation of epithelial cell proliferation | 3.728889e-4 |
GO:0071353 | cellular response to interleukin-4 | 3.773799e-4 |
GO:0045785 | positive regulation of cell adhesion | 3.800685e-4 |
GO:0032495 | response to muramyl dipeptide | 3.834948e-4 |
GO:0048608 | reproductive structure development | 3.847161e-4 |
GO:0016337 | cell-cell adhesion | 3.863471e-4 |
GO:0061138 | morphogenesis of a branching epithelium | 3.869082e-4 |
GO:0007283 | spermatogenesis | 3.870398e-4 |
GO:0001944 | vasculature development | 3.872989e-4 |
GO:0051234 | establishment of localization | 3.910071e-4 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.937165e-4 |
GO:0070682 | proteasome regulatory particle assembly | 3.938152e-4 |
GO:0032720 | negative regulation of tumor necrosis factor production | 3.954553e-4 |
GO:2000345 | regulation of hepatocyte proliferation | 3.991357e-4 |
GO:0030048 | actin filament-based movement | 4.049042e-4 |
GO:0048523 | negative regulation of cellular process | 4.070930e-4 |
GO:0009112 | nucleobase metabolic process | 4.073167e-4 |
GO:0046395 | carboxylic acid catabolic process | 4.213600e-4 |
GO:0050951 | sensory perception of temperature stimulus | 4.217777e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 4.217777e-4 |
GO:0018993 | somatic sex determination | 4.255410e-4 |
GO:0001763 | morphogenesis of a branching structure | 4.397354e-4 |
GO:0048754 | branching morphogenesis of a tube | 4.397403e-4 |
GO:0044237 | cellular metabolic process | 4.449170e-4 |
GO:0002009 | morphogenesis of an epithelium | 4.508696e-4 |
GO:0008284 | positive regulation of cell proliferation | 4.549957e-4 |
GO:0006520 | cellular amino acid metabolic process | 4.600559e-4 |
GO:0055093 | response to hyperoxia | 4.616570e-4 |
GO:0006627 | protein processing involved in protein targeting to mitochondrion | 4.655220e-4 |
GO:0071294 | cellular response to zinc ion | 4.655220e-4 |
GO:0051251 | positive regulation of lymphocyte activation | 4.678698e-4 |
GO:0050727 | regulation of inflammatory response | 4.691411e-4 |
GO:0001553 | luteinization | 4.727666e-4 |
GO:0001817 | regulation of cytokine production | 4.744543e-4 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 4.775376e-4 |
GO:0007411 | axon guidance | 4.788640e-4 |
GO:0001922 | B-1 B cell homeostasis | 4.799967e-4 |
GO:0018130 | heterocycle biosynthetic process | 4.814148e-4 |
GO:0060336 | negative regulation of interferon-gamma-mediated signaling pathway | 4.822923e-4 |
GO:0046686 | response to cadmium ion | 4.851802e-4 |
GO:0021516 | dorsal spinal cord development | 4.870957e-4 |
GO:0043403 | skeletal muscle tissue regeneration | 4.882283e-4 |
GO:0050690 | regulation of defense response to virus by virus | 4.907404e-4 |
GO:0018199 | peptidyl-glutamine modification | 4.913730e-4 |
GO:0030916 | otic vesicle formation | 4.929306e-4 |
GO:0046394 | carboxylic acid biosynthetic process | 5.022086e-4 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 5.056692e-4 |
GO:0006670 | sphingosine metabolic process | 5.103710e-4 |
GO:0048546 | digestive tract morphogenesis | 5.151554e-4 |
GO:0070741 | response to interleukin-6 | 5.184454e-4 |
GO:0009991 | response to extracellular stimulus | 5.205643e-4 |
GO:0030049 | muscle filament sliding | 5.221475e-4 |
GO:0042159 | lipoprotein catabolic process | 5.476354e-4 |
GO:0014038 | regulation of Schwann cell differentiation | 5.546525e-4 |
GO:0009123 | nucleoside monophosphate metabolic process | 5.572364e-4 |
GO:0030168 | platelet activation | 5.629446e-4 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 5.710843e-4 |
GO:0008637 | apoptotic mitochondrial changes | 5.767937e-4 |
GO:0002906 | negative regulation of mature B cell apoptosis | 5.779766e-4 |
GO:0021915 | neural tube development | 5.832257e-4 |
GO:0030198 | extracellular matrix organization | 5.834681e-4 |
GO:0021999 | neural plate anterior/posterior regionalization | 5.862815e-4 |
GO:0045619 | regulation of lymphocyte differentiation | 5.875855e-4 |
GO:0045071 | negative regulation of viral genome replication | 6.052386e-4 |
GO:0060907 | positive regulation of macrophage cytokine production | 6.107423e-4 |
GO:0002246 | wound healing involved in inflammatory response | 6.115251e-4 |
GO:0001934 | positive regulation of protein phosphorylation | 6.178153e-4 |
GO:0048589 | developmental growth | 6.335159e-4 |
GO:0006941 | striated muscle contraction | 6.336227e-4 |
GO:0002520 | immune system development | 6.383076e-4 |
GO:0051094 | positive regulation of developmental process | 6.403901e-4 |
GO:0030903 | notochord development | 6.459291e-4 |
GO:0022614 | membrane to membrane docking | 6.518093e-4 |
GO:0042448 | progesterone metabolic process | 6.520080e-4 |
GO:0033121 | regulation of purine nucleotide catabolic process | 6.523695e-4 |
GO:0060346 | bone trabecula formation | 6.548520e-4 |
GO:0042364 | water-soluble vitamin biosynthetic process | 6.551934e-4 |
GO:0048511 | rhythmic process | 6.596163e-4 |
GO:0009165 | nucleotide biosynthetic process | 6.725824e-4 |
GO:0061061 | muscle structure development | 6.734346e-4 |
GO:0019674 | NAD metabolic process | 6.834474e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0048240 | sperm capacitation | 9.256051e-17 |
GO:0006952 | defense response | 3.221315e-15 |
GO:0042742 | defense response to bacterium | 9.358304e-12 |
GO:0045071 | negative regulation of viral genome replication | 1.048234e-11 |
GO:0048525 | negative regulation of viral reproduction | 1.508052e-11 |
GO:0008207 | C21-steroid hormone metabolic process | 1.811907e-11 |
GO:0045869 | negative regulation of retroviral genome replication | 3.152400e-11 |
GO:0006954 | inflammatory response | 5.660861e-11 |
GO:0006950 | response to stress | 1.404699e-10 |
GO:0055114 | oxidation-reduction process | 8.337727e-10 |
GO:0006629 | lipid metabolic process | 1.460008e-9 |
GO:0045091 | regulation of retroviral genome replication | 1.719718e-9 |
GO:0051704 | multi-organism process | 2.863028e-9 |
GO:0045947 | negative regulation of translational initiation | 2.946634e-9 |
GO:0050896 | response to stimulus | 3.344043e-9 |
GO:2000121 | regulation of removal of superoxide radicals | 3.509472e-9 |
GO:0009566 | fertilization | 3.965070e-9 |
GO:0042953 | lipoprotein transport | 4.122228e-9 |
GO:0060613 | fat pad development | 4.292101e-9 |
GO:0051707 | response to other organism | 7.502409e-9 |
GO:0034754 | cellular hormone metabolic process | 1.207230e-8 |
GO:0045834 | positive regulation of lipid metabolic process | 1.638213e-8 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 1.794987e-8 |
GO:0006704 | glucocorticoid biosynthetic process | 2.014183e-8 |
GO:0010883 | regulation of lipid storage | 2.271868e-8 |
GO:0022414 | reproductive process | 2.286646e-8 |
GO:0010155 | regulation of proton transport | 3.129407e-8 |
GO:0045006 | DNA deamination | 3.483656e-8 |
GO:0009617 | response to bacterium | 3.562307e-8 |
GO:0015911 | plasma membrane long-chain fatty acid transport | 3.914440e-8 |
GO:0006700 | C21-steroid hormone biosynthetic process | 4.004376e-8 |
GO:0050710 | negative regulation of cytokine secretion | 6.080076e-8 |
GO:0006810 | transport | 7.415077e-8 |
GO:0044255 | cellular lipid metabolic process | 7.560716e-8 |
GO:0008202 | steroid metabolic process | 7.805982e-8 |
GO:0045738 | negative regulation of DNA repair | 8.154250e-8 |
GO:0051023 | regulation of immunoglobulin secretion | 9.586326e-8 |
GO:0009607 | response to biotic stimulus | 1.024485e-7 |
GO:0003006 | developmental process involved in reproduction | 1.230373e-7 |
GO:0000003 | reproduction | 1.308338e-7 |
GO:0007276 | gamete generation | 1.464102e-7 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 1.876329e-7 |
GO:2001038 | regulation of cellular response to drug | 1.876329e-7 |
GO:2000685 | positive regulation of cellular response to X-ray | 1.876329e-7 |
GO:0035988 | chondrocyte proliferation | 1.876329e-7 |
GO:0031052 | chromosome breakage | 1.876329e-7 |
GO:0035978 | histone H2A-S139 phosphorylation | 1.876329e-7 |
GO:0003131 | mesodermal-endodermal cell signaling | 1.876329e-7 |
GO:0010743 | regulation of macrophage derived foam cell differentiation | 2.209874e-7 |
GO:0051234 | establishment of localization | 5.531319e-7 |
GO:0030325 | adrenal gland development | 5.655060e-7 |
GO:0045190 | isotype switching | 5.823103e-7 |
GO:0008211 | glucocorticoid metabolic process | 6.593929e-7 |
GO:0019433 | triglyceride catabolic process | 6.707538e-7 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 8.125745e-7 |
GO:0061041 | regulation of wound healing | 8.507477e-7 |
GO:0051179 | localization | 8.584210e-7 |
GO:0007512 | adult heart development | 9.278535e-7 |
GO:0006641 | triglyceride metabolic process | 9.881875e-7 |
GO:0048515 | spermatid differentiation | 1.192587e-6 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.230751e-6 |
GO:0015860 | purine nucleoside transport | 1.232841e-6 |
GO:0090322 | regulation of superoxide metabolic process | 1.235157e-6 |
GO:0080134 | regulation of response to stress | 1.719414e-6 |
GO:0051883 | killing of cells in other organism involved in symbiotic interaction | 2.056716e-6 |
GO:0042448 | progesterone metabolic process | 2.062857e-6 |
GO:0002366 | leukocyte activation involved in immune response | 2.133247e-6 |
GO:0072527 | pyrimidine-containing compound metabolic process | 2.254409e-6 |
GO:0019836 | hemolysis by symbiont of host erythrocytes | 2.285154e-6 |
GO:0046689 | response to mercury ion | 2.369437e-6 |
GO:0045137 | development of primary sexual characteristics | 2.423061e-6 |
GO:0031640 | killing of cells of other organism | 2.646187e-6 |
GO:0019953 | sexual reproduction | 3.020601e-6 |
GO:0031953 | negative regulation of protein autophosphorylation | 3.810992e-6 |
GO:0072091 | regulation of stem cell proliferation | 3.941190e-6 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 4.049357e-6 |
GO:2000648 | positive regulation of stem cell proliferation | 4.070771e-6 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 4.183471e-6 |
GO:0006091 | generation of precursor metabolites and energy | 4.677549e-6 |
GO:0015980 | energy derivation by oxidation of organic compounds | 4.961688e-6 |
GO:0051240 | positive regulation of multicellular organismal process | 5.431307e-6 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 5.517247e-6 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 5.547801e-6 |
GO:0006642 | triglyceride mobilization | 5.878317e-6 |
GO:0051235 | maintenance of location | 5.970533e-6 |
GO:0050709 | negative regulation of protein secretion | 6.106622e-6 |
GO:0050873 | brown fat cell differentiation | 6.191973e-6 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 6.476937e-6 |
GO:0043901 | negative regulation of multi-organism process | 6.480902e-6 |
GO:0017148 | negative regulation of translation | 6.839147e-6 |
GO:0006310 | DNA recombination | 6.900717e-6 |
GO:0002449 | lymphocyte mediated immunity | 6.979026e-6 |
GO:0051657 | maintenance of organelle location | 6.980994e-6 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 7.249415e-6 |
GO:0051645 | Golgi localization | 7.312349e-6 |
GO:0051659 | maintenance of mitochondrion location | 7.383423e-6 |
GO:0071447 | cellular response to hydroperoxide | 7.392329e-6 |
GO:0048557 | embryonic digestive tract morphogenesis | 7.418973e-6 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 7.960608e-6 |
GO:0031034 | myosin filament assembly | 8.296823e-6 |
GO:0046503 | glycerolipid catabolic process | 8.596976e-6 |
GO:0046464 | acylglycerol catabolic process | 8.702620e-6 |
GO:0032649 | regulation of interferon-gamma production | 9.083411e-6 |
GO:0048305 | immunoglobulin secretion | 9.512398e-6 |
GO:0045649 | regulation of macrophage differentiation | 9.612947e-6 |
GO:0071356 | cellular response to tumor necrosis factor | 9.631147e-6 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.003862e-5 |
GO:0007548 | sex differentiation | 1.013518e-5 |
GO:0010817 | regulation of hormone levels | 1.051762e-5 |
GO:0018904 | organic ether metabolic process | 1.119600e-5 |
GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 1.149747e-5 |
GO:0002312 | B cell activation involved in immune response | 1.167039e-5 |
GO:0030261 | chromosome condensation | 1.312445e-5 |
GO:0021548 | pons development | 1.441209e-5 |
GO:0043410 | positive regulation of MAPKKK cascade | 1.557151e-5 |
GO:0050820 | positive regulation of coagulation | 1.578638e-5 |
GO:0048584 | positive regulation of response to stimulus | 1.629859e-5 |
GO:0051239 | regulation of multicellular organismal process | 1.638181e-5 |
GO:0032656 | regulation of interleukin-13 production | 1.652963e-5 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.682308e-5 |
GO:0030194 | positive regulation of blood coagulation | 1.747382e-5 |
GO:0045069 | regulation of viral genome replication | 1.807201e-5 |
GO:0007283 | spermatogenesis | 1.847662e-5 |
GO:0070541 | response to platinum ion | 1.849439e-5 |
GO:0044281 | small molecule metabolic process | 1.892137e-5 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 1.904741e-5 |
GO:0046330 | positive regulation of JNK cascade | 1.967794e-5 |
GO:0048519 | negative regulation of biological process | 1.989228e-5 |
GO:0002676 | regulation of chronic inflammatory response | 1.993055e-5 |
GO:0007623 | circadian rhythm | 2.015398e-5 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 2.018746e-5 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 2.034348e-5 |
GO:0045650 | negative regulation of macrophage differentiation | 2.079074e-5 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 2.094201e-5 |
GO:0021754 | facial nucleus development | 2.094201e-5 |
GO:0001817 | regulation of cytokine production | 2.258386e-5 |
GO:0060008 | Sertoli cell differentiation | 2.342701e-5 |
GO:0007281 | germ cell development | 2.387741e-5 |
GO:0002686 | negative regulation of leukocyte migration | 2.388382e-5 |
GO:0048609 | multicellular organismal reproductive process | 2.391599e-5 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.416098e-5 |
GO:0045940 | positive regulation of steroid metabolic process | 2.460356e-5 |
GO:0072529 | pyrimidine-containing compound catabolic process | 2.472043e-5 |
GO:0006662 | glycerol ether metabolic process | 2.602704e-5 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 2.711262e-5 |
GO:0006446 | regulation of translational initiation | 2.814221e-5 |
GO:2000334 | positive regulation of blood microparticle formation | 2.987275e-5 |
GO:0032269 | negative regulation of cellular protein metabolic process | 3.084088e-5 |
GO:0008610 | lipid biosynthetic process | 3.104691e-5 |
GO:0019752 | carboxylic acid metabolic process | 3.262175e-5 |
GO:0009972 | cytidine deamination | 3.317172e-5 |
GO:0048512 | circadian behavior | 3.329524e-5 |
GO:0002544 | chronic inflammatory response | 3.571043e-5 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 3.612004e-5 |
GO:0001775 | cell activation | 3.718068e-5 |
GO:0019722 | calcium-mediated signaling | 3.850216e-5 |
GO:0043589 | skin morphogenesis | 3.854355e-5 |
GO:0044130 | negative regulation of growth of symbiont in host | 3.871469e-5 |
GO:0042753 | positive regulation of circadian rhythm | 3.922630e-5 |
GO:0010529 | negative regulation of transposition | 4.098014e-5 |
GO:0070383 | DNA cytosine deamination | 4.098014e-5 |
GO:0045988 | negative regulation of striated muscle contraction | 4.166458e-5 |
GO:0002682 | regulation of immune system process | 4.193400e-5 |
GO:0043900 | regulation of multi-organism process | 4.402207e-5 |
GO:0019216 | regulation of lipid metabolic process | 4.461359e-5 |
GO:0006639 | acylglycerol metabolic process | 4.533136e-5 |
GO:0042221 | response to chemical stimulus | 4.565035e-5 |
GO:0002440 | production of molecular mediator of immune response | 4.565661e-5 |
GO:0006930 | substrate-dependent cell migration, cell extension | 4.590518e-5 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.590518e-5 |
GO:0042180 | cellular ketone metabolic process | 4.654374e-5 |
GO:0050818 | regulation of coagulation | 4.679518e-5 |
GO:0008406 | gonad development | 4.799728e-5 |
GO:0065007 | biological regulation | 4.949234e-5 |
GO:0007286 | spermatid development | 4.993407e-5 |
GO:0051100 | negative regulation of binding | 5.099388e-5 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 5.267397e-5 |
GO:0031649 | heat generation | 5.458907e-5 |
GO:0030193 | regulation of blood coagulation | 5.508422e-5 |
GO:0045346 | regulation of MHC class II biosynthetic process | 5.666069e-5 |
GO:0002443 | leukocyte mediated immunity | 5.724751e-5 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 5.803536e-5 |
GO:0019218 | regulation of steroid metabolic process | 5.907541e-5 |
GO:0019724 | B cell mediated immunity | 5.920796e-5 |
GO:0051716 | cellular response to stimulus | 6.026126e-5 |
GO:0034612 | response to tumor necrosis factor | 6.028603e-5 |
GO:0001818 | negative regulation of cytokine production | 6.333735e-5 |
GO:0043252 | sodium-independent organic anion transport | 6.388759e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 6.452795e-5 |
GO:0002678 | positive regulation of chronic inflammatory response | 6.700750e-5 |
GO:0044242 | cellular lipid catabolic process | 6.743005e-5 |
GO:0014003 | oligodendrocyte development | 6.904915e-5 |
GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine | 6.911801e-5 |
GO:0051970 | negative regulation of transmission of nerve impulse | 7.066485e-5 |
GO:0016064 | immunoglobulin mediated immune response | 7.391673e-5 |
GO:0006082 | organic acid metabolic process | 7.486870e-5 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 7.596105e-5 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.716397e-5 |
GO:0043309 | regulation of eosinophil degranulation | 7.773855e-5 |
GO:0006909 | phagocytosis | 7.838665e-5 |
GO:0048545 | response to steroid hormone stimulus | 7.866824e-5 |
GO:0003096 | renal sodium ion transport | 8.430475e-5 |
GO:0032782 | bile acid secretion | 8.430475e-5 |
GO:0044419 | interspecies interaction between organisms | 8.526540e-5 |
GO:0016445 | somatic diversification of immunoglobulins | 8.715247e-5 |
GO:0010466 | negative regulation of peptidase activity | 8.824523e-5 |
GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 9.248921e-5 |
GO:0048566 | embryonic digestive tract development | 9.725780e-5 |
GO:0051224 | negative regulation of protein transport | 9.875376e-5 |
GO:0030643 | cellular phosphate ion homeostasis | 1.041249e-4 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 1.053448e-4 |
GO:0002831 | regulation of response to biotic stimulus | 1.061384e-4 |
GO:0046325 | negative regulation of glucose import | 1.081352e-4 |
GO:0019915 | lipid storage | 1.100773e-4 |
GO:0034383 | low-density lipoprotein particle clearance | 1.136167e-4 |
GO:0032689 | negative regulation of interferon-gamma production | 1.136167e-4 |
GO:0042574 | retinal metabolic process | 1.139889e-4 |
GO:0050805 | negative regulation of synaptic transmission | 1.155698e-4 |
GO:0090402 | oncogene-induced senescence | 1.167864e-4 |
GO:2000774 | positive regulation of cellular senescence | 1.167864e-4 |
GO:0035986 | senescence-associated heterochromatin focus formation | 1.167864e-4 |
GO:0006955 | immune response | 1.178682e-4 |
GO:0032680 | regulation of tumor necrosis factor production | 1.188197e-4 |
GO:0010888 | negative regulation of lipid storage | 1.235303e-4 |
GO:0043277 | apoptotic cell clearance | 1.253282e-4 |
GO:0046546 | development of primary male sexual characteristics | 1.266370e-4 |
GO:0045333 | cellular respiration | 1.275629e-4 |
GO:0007622 | rhythmic behavior | 1.287847e-4 |
GO:0044341 | sodium-dependent phosphate transport | 1.304155e-4 |
GO:0050830 | defense response to Gram-positive bacterium | 1.310766e-4 |
GO:0042445 | hormone metabolic process | 1.324616e-4 |
GO:0009719 | response to endogenous stimulus | 1.332840e-4 |
GO:0031952 | regulation of protein autophosphorylation | 1.391937e-4 |
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | 1.406325e-4 |
GO:0008584 | male gonad development | 1.418536e-4 |
GO:0051101 | regulation of DNA binding | 1.439326e-4 |
GO:2000772 | regulation of cellular senescence | 1.505670e-4 |
GO:0032655 | regulation of interleukin-12 production | 1.528829e-4 |
GO:0045321 | leukocyte activation | 1.557378e-4 |
GO:0032653 | regulation of interleukin-10 production | 1.581870e-4 |
GO:0071221 | cellular response to bacterial lipopeptide | 1.616473e-4 |
GO:0051248 | negative regulation of protein metabolic process | 1.642393e-4 |
GO:0006942 | regulation of striated muscle contraction | 1.642795e-4 |
GO:0007009 | plasma membrane organization | 1.661457e-4 |
GO:0032733 | positive regulation of interleukin-10 production | 1.678332e-4 |
GO:0060123 | regulation of growth hormone secretion | 1.688924e-4 |
GO:0031645 | negative regulation of neurological system process | 1.691841e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 1.725644e-4 |
GO:0002377 | immunoglobulin production | 1.856779e-4 |
GO:0051640 | organelle localization | 1.862834e-4 |
GO:0030728 | ovulation | 1.883724e-4 |
GO:0008286 | insulin receptor signaling pathway | 1.899038e-4 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.929755e-4 |
GO:0051651 | maintenance of location in cell | 1.932815e-4 |
GO:0051586 | positive regulation of dopamine uptake | 1.933734e-4 |
GO:2000279 | negative regulation of DNA biosynthetic process | 1.975378e-4 |
GO:0032735 | positive regulation of interleukin-12 production | 1.976302e-4 |
GO:0010885 | regulation of cholesterol storage | 1.979352e-4 |
GO:0006929 | substrate-dependent cell migration | 2.003171e-4 |
GO:0045444 | fat cell differentiation | 2.064946e-4 |
GO:0060341 | regulation of cellular localization | 2.071986e-4 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 2.147742e-4 |
GO:0001906 | cell killing | 2.171274e-4 |
GO:0010829 | negative regulation of glucose transport | 2.198343e-4 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 2.199526e-4 |
GO:0032642 | regulation of chemokine production | 2.217645e-4 |
GO:0010460 | positive regulation of heart rate | 2.240122e-4 |
GO:0002285 | lymphocyte activation involved in immune response | 2.254579e-4 |
GO:0048518 | positive regulation of biological process | 2.257953e-4 |
GO:0021678 | third ventricle development | 2.274691e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.279013e-4 |
GO:0009725 | response to hormone stimulus | 2.287179e-4 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 2.296932e-4 |
GO:0006206 | pyrimidine base metabolic process | 2.351913e-4 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 2.395051e-4 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.468561e-4 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.468561e-4 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.468561e-4 |
GO:0015872 | dopamine transport | 2.490377e-4 |
GO:0045065 | cytotoxic T cell differentiation | 2.506765e-4 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 2.521973e-4 |
GO:0009611 | response to wounding | 2.582686e-4 |
GO:0043392 | negative regulation of DNA binding | 2.617139e-4 |
GO:0050994 | regulation of lipid catabolic process | 2.645432e-4 |
GO:0010906 | regulation of glucose metabolic process | 2.666960e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.681555e-4 |
GO:0033993 | response to lipid | 2.723583e-4 |
GO:0042474 | middle ear morphogenesis | 2.750988e-4 |
GO:0070257 | positive regulation of mucus secretion | 2.776062e-4 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 2.845250e-4 |
GO:2000779 | regulation of double-strand break repair | 2.905987e-4 |
GO:0070255 | regulation of mucus secretion | 2.991349e-4 |
GO:0006638 | neutral lipid metabolic process | 3.148263e-4 |
GO:0017126 | nucleologenesis | 3.195591e-4 |
GO:0034381 | plasma lipoprotein particle clearance | 3.225207e-4 |
GO:0031668 | cellular response to extracellular stimulus | 3.232285e-4 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 3.305001e-4 |
GO:0050789 | regulation of biological process | 3.323981e-4 |
GO:0051181 | cofactor transport | 3.443864e-4 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 3.479157e-4 |
GO:0051583 | dopamine uptake | 3.479157e-4 |
GO:0051461 | positive regulation of corticotropin secretion | 3.479880e-4 |
GO:2000683 | regulation of cellular response to X-ray | 3.483875e-4 |
GO:0001983 | baroreceptor response to increased systemic arterial blood pressure | 3.483875e-4 |
GO:0006643 | membrane lipid metabolic process | 3.551417e-4 |
GO:0007605 | sensory perception of sound | 3.582495e-4 |
GO:0002526 | acute inflammatory response | 3.594518e-4 |
GO:0010884 | positive regulation of lipid storage | 3.656252e-4 |
GO:0010886 | positive regulation of cholesterol storage | 3.694158e-4 |
GO:0021682 | nerve maturation | 3.705797e-4 |
GO:0019482 | beta-alanine metabolic process | 3.705797e-4 |
GO:0002839 | positive regulation of immune response to tumor cell | 3.707239e-4 |
GO:0010033 | response to organic substance | 3.752610e-4 |
GO:0061037 | negative regulation of cartilage development | 3.957076e-4 |
GO:0060324 | face development | 3.964064e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 3.980860e-4 |
GO:0071361 | cellular response to ethanol | 4.003476e-4 |
GO:0044062 | regulation of excretion | 4.178107e-4 |
GO:0071875 | adrenergic receptor signaling pathway | 4.178107e-4 |
GO:0045776 | negative regulation of blood pressure | 4.199172e-4 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 4.262151e-4 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 4.262151e-4 |
GO:0002376 | immune system process | 4.373671e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.395413e-4 |
GO:0021592 | fourth ventricle development | 4.403905e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 4.430927e-4 |
GO:0045777 | positive regulation of blood pressure | 4.519954e-4 |
GO:0071496 | cellular response to external stimulus | 4.595812e-4 |
GO:0021539 | subthalamus development | 4.918659e-4 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 4.926548e-4 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 4.976490e-4 |
GO:0060009 | Sertoli cell development | 4.979795e-4 |
GO:0048625 | myoblast cell fate commitment | 5.003390e-4 |
GO:0002837 | regulation of immune response to tumor cell | 5.005378e-4 |
GO:0014013 | regulation of gliogenesis | 5.037991e-4 |
GO:0006665 | sphingolipid metabolic process | 5.108128e-4 |
GO:0071705 | nitrogen compound transport | 5.113130e-4 |
GO:0050707 | regulation of cytokine secretion | 5.190574e-4 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 5.224699e-4 |
GO:0022900 | electron transport chain | 5.233746e-4 |
GO:0010872 | regulation of cholesterol esterification | 5.329050e-4 |
GO:0051701 | interaction with host | 5.349520e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 5.388265e-4 |
GO:0015858 | nucleoside transport | 5.388265e-4 |
GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback | 5.423237e-4 |
GO:0000070 | mitotic sister chromatid segregation | 5.452888e-4 |
GO:0021846 | cell proliferation in forebrain | 5.467368e-4 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 5.534284e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.586816e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.586816e-4 |
GO:0006910 | phagocytosis, recognition | 5.602474e-4 |
GO:0000819 | sister chromatid segregation | 5.607428e-4 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 5.616874e-4 |
GO:0045994 | positive regulation of translational initiation by iron | 5.616874e-4 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 5.616874e-4 |
GO:0002037 | negative regulation of L-glutamate transport | 5.616874e-4 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5.647678e-4 |
GO:0006259 | DNA metabolic process | 5.692472e-4 |
GO:0048523 | negative regulation of cellular process | 5.927027e-4 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 5.950631e-4 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 5.954043e-4 |
GO:0072061 | inner medullary collecting duct development | 6.010745e-4 |
GO:0072060 | outer medullary collecting duct development | 6.010745e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 6.010745e-4 |
GO:0010608 | posttranscriptional regulation of gene expression | 6.093383e-4 |
GO:0022610 | biological adhesion | 6.166498e-4 |
GO:2000242 | negative regulation of reproductive process | 6.211894e-4 |
GO:0033057 | multicellular organismal reproductive behavior | 6.220551e-4 |
GO:0055062 | phosphate ion homeostasis | 6.229707e-4 |
GO:0070873 | regulation of glycogen metabolic process | 6.263475e-4 |
GO:0010873 | positive regulation of cholesterol esterification | 6.468357e-4 |
GO:0006694 | steroid biosynthetic process | 6.523038e-4 |
GO:0002250 | adaptive immune response | 6.571347e-4 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 6.574024e-4 |
GO:0043388 | positive regulation of DNA binding | 6.607801e-4 |
GO:0035411 | catenin import into nucleus | 6.615799e-4 |
GO:0008016 | regulation of heart contraction | 6.640249e-4 |
GO:0052547 | regulation of peptidase activity | 6.733081e-4 |
GO:0051125 | regulation of actin nucleation | 6.839800e-4 |
GO:0007155 | cell adhesion | 6.843885e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 6.959958e-4 |
GO:0030730 | sequestering of triglyceride | 6.959958e-4 |
GO:0048610 | cellular process involved in reproduction | 7.439297e-4 |
GO:0046520 | sphingoid biosynthetic process | 7.456829e-4 |
GO:0003073 | regulation of systemic arterial blood pressure | 7.618467e-4 |
GO:0010647 | positive regulation of cell communication | 7.663565e-4 |
GO:0045924 | regulation of female receptivity | 7.775003e-4 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 7.886019e-4 |
GO:0002200 | somatic diversification of immune receptors | 7.963766e-4 |
GO:0050673 | epithelial cell proliferation | 8.088097e-4 |
GO:0009892 | negative regulation of metabolic process | 8.139542e-4 |
GO:0030168 | platelet activation | 8.178330e-4 |
GO:0071222 | cellular response to lipopolysaccharide | 8.307632e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 8.335608e-4 |
GO:0006109 | regulation of carbohydrate metabolic process | 8.393686e-4 |
GO:0007621 | negative regulation of female receptivity | 8.774061e-4 |
GO:0031424 | keratinization | 8.787813e-4 |
GO:0031507 | heterochromatin formation | 8.916219e-4 |
GO:0030317 | sperm motility | 8.925291e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 8.959976e-4 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 8.984767e-4 |
GO:0032847 | regulation of cellular pH reduction | 9.041098e-4 |
GO:0051937 | catecholamine transport | 9.160783e-4 |
GO:0046006 | regulation of activated T cell proliferation | 9.176404e-4 |
GO:0002237 | response to molecule of bacterial origin | 9.196628e-4 |
GO:0048251 | elastic fiber assembly | 9.236453e-4 |
GO:0032274 | gonadotropin secretion | 9.262237e-4 |
GO:0048546 | digestive tract morphogenesis | 9.390764e-4 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 9.452180e-4 |
GO:0050792 | regulation of viral reproduction | 9.477216e-4 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 9.668328e-4 |
GO:0046513 | ceramide biosynthetic process | 9.681476e-4 |
GO:0002252 | immune effector process | 1.009108e-3 |
GO:0002833 | positive regulation of response to biotic stimulus | 1.019039e-3 |
GO:0032496 | response to lipopolysaccharide | 1.021865e-3 |
GO:0071702 | organic substance transport | 1.039935e-3 |
GO:0046466 | membrane lipid catabolic process | 1.040516e-3 |
GO:0006911 | phagocytosis, engulfment | 1.058270e-3 |
GO:0070995 | NADPH oxidation | 1.060869e-3 |
GO:0034435 | cholesterol esterification | 1.064356e-3 |
GO:0007126 | meiosis | 1.089700e-3 |
GO:0060312 | regulation of blood vessel remodeling | 1.102125e-3 |
GO:0006323 | DNA packaging | 1.102166e-3 |
GO:0015850 | organic alcohol transport | 1.103783e-3 |
GO:0044092 | negative regulation of molecular function | 1.115456e-3 |
GO:0032879 | regulation of localization | 1.146735e-3 |
GO:0043408 | regulation of MAPKKK cascade | 1.157357e-3 |
GO:0071219 | cellular response to molecule of bacterial origin | 1.158921e-3 |
GO:0032673 | regulation of interleukin-4 production | 1.163197e-3 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.170724e-3 |
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 1.170724e-3 |
GO:0051321 | meiotic cell cycle | 1.196545e-3 |
GO:0032944 | regulation of mononuclear cell proliferation | 1.197917e-3 |
GO:0034440 | lipid oxidation | 1.200928e-3 |
GO:0051046 | regulation of secretion | 1.204566e-3 |
GO:0072053 | renal inner medulla development | 1.209654e-3 |
GO:0017144 | drug metabolic process | 1.212523e-3 |
GO:0030853 | negative regulation of granulocyte differentiation | 1.227343e-3 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.229405e-3 |
GO:0006844 | acyl carnitine transport | 1.229405e-3 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.239297e-3 |
GO:0033194 | response to hydroperoxide | 1.239862e-3 |
GO:0060556 | regulation of vitamin D biosynthetic process | 1.241751e-3 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.241979e-3 |
GO:0002125 | maternal aggressive behavior | 1.242981e-3 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 1.247846e-3 |
GO:0032101 | regulation of response to external stimulus | 1.262556e-3 |
GO:0008152 | metabolic process | 1.302808e-3 |
GO:0050954 | sensory perception of mechanical stimulus | 1.309330e-3 |
GO:0002281 | macrophage activation involved in immune response | 1.318589e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.318732e-3 |
GO:0006721 | terpenoid metabolic process | 1.336570e-3 |
GO:0002115 | store-operated calcium entry | 1.338815e-3 |
GO:0071803 | positive regulation of podosome assembly | 1.338815e-3 |
GO:0070201 | regulation of establishment of protein localization | 1.352329e-3 |
GO:0009112 | nucleobase metabolic process | 1.355197e-3 |
GO:0032859 | activation of Ral GTPase activity | 1.374018e-3 |
GO:0019229 | regulation of vasoconstriction | 1.391195e-3 |
GO:0051346 | negative regulation of hydrolase activity | 1.413544e-3 |
GO:0060010 | Sertoli cell fate commitment | 1.447370e-3 |
GO:0016098 | monoterpenoid metabolic process | 1.447370e-3 |
GO:0002275 | myeloid cell activation involved in immune response | 1.456831e-3 |
GO:0050670 | regulation of lymphocyte proliferation | 1.458528e-3 |
GO:0021570 | rhombomere 4 development | 1.472465e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 1.472465e-3 |
GO:2000273 | positive regulation of receptor activity | 1.486241e-3 |
GO:0046661 | male sex differentiation | 1.488937e-3 |
GO:0032456 | endocytic recycling | 1.492372e-3 |
GO:0071103 | DNA conformation change | 1.496730e-3 |
GO:0080135 | regulation of cellular response to stress | 1.506987e-3 |
GO:0009615 | response to virus | 1.514813e-3 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 1.547561e-3 |
GO:0072054 | renal outer medulla development | 1.553244e-3 |
GO:0015931 | nucleobase-containing compound transport | 1.561218e-3 |
GO:0051984 | positive regulation of chromosome segregation | 1.575022e-3 |
GO:0034498 | early endosome to Golgi transport | 1.575022e-3 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.575022e-3 |
GO:0034337 | RNA folding | 1.577503e-3 |
GO:0032722 | positive regulation of chemokine production | 1.580694e-3 |
GO:0046135 | pyrimidine nucleoside catabolic process | 1.582664e-3 |
GO:0000027 | ribosomal large subunit assembly | 1.597917e-3 |
GO:0046293 | formaldehyde biosynthetic process | 1.597917e-3 |
GO:0031324 | negative regulation of cellular metabolic process | 1.598134e-3 |
GO:0060262 | negative regulation of N-terminal protein palmitoylation | 1.598346e-3 |
GO:0016482 | cytoplasmic transport | 1.598346e-3 |
GO:0051103 | DNA ligation involved in DNA repair | 1.606554e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 1.608504e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 1.611530e-3 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 1.623353e-3 |
GO:0072659 | protein localization in plasma membrane | 1.640238e-3 |
GO:0015884 | folic acid transport | 1.642494e-3 |
GO:0043200 | response to amino acid stimulus | 1.656273e-3 |
GO:0006937 | regulation of muscle contraction | 1.686224e-3 |
GO:0023056 | positive regulation of signaling | 1.688740e-3 |
GO:0044106 | cellular amine metabolic process | 1.689608e-3 |
GO:0010810 | regulation of cell-substrate adhesion | 1.699643e-3 |
GO:0032501 | multicellular organismal process | 1.721464e-3 |
GO:0010646 | regulation of cell communication | 1.778175e-3 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 1.789279e-3 |
GO:0032674 | regulation of interleukin-5 production | 1.814861e-3 |